Determinants of differential doxorubicin sensitivity between SCLC and NSCLC
The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
Doxorubicin (DOX) transport activity of Ral‐interacting protein (RLIP76) in non‐small cell lung cancer (NSCLC) is approximately twice that of in small cell lung cancer (SCLC). Since protein‐kinase‐C (PKC)α mediated phosphorylation of RLIP76 causes doubling of the specific activity of RLIP76, and NSCLC cells are known to have greater PKCα activity, we examined the contribution of PKC mediated phosphorylation of RLIP76 towards intrinsic DOX‐resistance in human NSCLC. Expression of a deletion mutant RLIP76 delPKCα‐sites followed by depletion of the wild‐type RLIP76 using a siRNA targeted at one of the deleted regions resulted in generation of cells expressing only the mutant protein, which could not be phosphorylated by PKCα. DOX‐transport activity of the mutant RLIP76 purified from NSCLC and SCLC was similar and comparable to that of RLIP76 purified from the wild‐type SCLC. However, this activity was significantly lower than that of RLIP76 purified from the wild‐type NSCLC. After siRNA mediated depletion of PKCα, DOX‐transport activities of RLIP76 purified from SCLC and NSCLC were indistinguishable. Depletion of PKCα inhibited the growth of NSCLC more than SCLC cells (70 ± 3% vs. 43 ± 5%, respectively). PKCα‐depletion lowered the IC 50 of NSCLC cell lines for DOX to the same level as that observed for SCLC. RLIP76−/− mouse embryonic fibroblasts (MEFs) were significantly more sensitive to DOX as compared with RLIP76+/+ MEFs (IC 50 25 vs. 125 nM, respectively). However, PKCα‐depletion did not affect DOX‐cytotoxicity towards RLIP76−/− MEFs, as opposed to RLIP76+/+ MEFs which were sensitized by 2.2‐fold. These results demonstrate that RLIP76 is a primary determinant of DOX‐resistance, and that PKCα mediated accumulation defect and DOX‐resistance in NSCLC is primarily due to differential phosphorylation of RLIP76 in SCLC and NSCLC.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bridging Ral GTPase to Rho Pathways
Jullien-Flores, V., Dorseuil, O., Romero, F., Letourneur, F., Saragosti, S., Berger, R., Tavitian, A., Gacon, G., & Camonis, J. H. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.38.22473 · Cited by 338
Cheng, J.-Z., Sharma, R., Yang, Y., Singhal, S. S., Sharma, A., Saini, M. K., Singh, S. V., Zimniak, P., Awasthi, S., & Awasthi, Y. C. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m106838200 · Cited by 185
Self-citationNovel function of human RLIP76: ATP-dependent transport of glutathione conjugates and doxorubicin
Awasthi, S., Cheng, J., Singhal, S. S., Saini, M. K., Pandya, U., Pikula, S., Bandorowicz-Pikula, J., Singh, S. V., Zimniak, P., & Awasthi, Y. C. (2000) · Biochemistry · doi:10.1021/bi992964c · Cited by 159
Self-citationAwasthi, S., Singhal, S. S., Sharma, R., Zimniak, P., & Awasthi, Y. C. (2003) · International Journal of Cancer · doi:10.1002/ijc.11260 · Cited by 120
Self-citationYang, Y., Sharma, A., Sharma, R., Patrick, B., Singhal, S. S., Zimniak, P., Awasthi, S., & Awasthi, Y. C. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m305766200 · Cited by 90
Self-citationRLIP76 is a major determinant of radiation sensitivity
Awasthi, S., Singhal, S. S., Yadav, S., Singhal, J., Drake, K., Nadkar, A., Zajac, E., Wickramarachchi, D., Rowe, N., Yacoub, A., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0968 · Cited by 88 · cited 1×
“Greater than 80% loss in liver and heart tissue of total DOX and GS-E transport activity in RLIP76 knockout mice [16] strongly supports the hypothesis that RLIP76 can contribute substantially to total DOX-trans-”
BackgroundSelf-citation
Cited by
Roberts, A. M., Watson, I. R., Evans, A. J., Foster, D. A., Irwin, M. S., & Ohh, M. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-1770 · Cited by 88
Singhal, S. S., Wickramarachchi, D., Yadav, S., Singhal, J., Leake, K., Vatsyayan, R., Chaudhary, P., Lelsani, P., Suzuki, S., Yang, S., et al. (2011) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-10-0699 · Cited by 62
“The lack of PKCa-proliferative effects shownpreviously inRLIP76 / MEFs is validated by present in vivo findings, and strongly indicates the phosphorylation of RLIP76 by PKCa is a necessary prerequisite for the hyperproliferative response to PMA (27, 30).”
BackgroundMethodSelf-citationProtein Kinase C as a Therapeutic Target in Non-Small Cell Lung Cancer
Sadeghi, M. M., Salama, M. F., & Hannun, Y. A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22115527 · Cited by 31
“PKCα has also been implicated in drug sensitivity and resistance acquisition and was reported to mediate doxorubicin sensitivity by phosphorylation of RLIP76 in NSCLC [40,41].”
BackgroundLal, S., Sutiman, N., Ooi, L. L., Wong, Z. W., Wong, N. S., Ang, P. C. S., & Chowbay, B. (2017) · The Pharmacogenomics Journal · doi:10.1038/tpj.2016.17 · Cited by 26
Metadata
- Authors
- Singhal, S. S., Wickramarachchi, D., Singhal, J., Yadav, S., Awasthi, Y. C., & Awasthi, S.
- Venue
- FEBS Letters
- Publisher
- Wiley
- Published
- 2006-03-24
- Volume
- 580
- Issue
- 9
- Pages
- 2258-2264
- ISSN
- 0014-5793 (ISSN-L)
- 1873-3468
- OpenAlex
- W2063294311
- Cited by
- 40
- References
- 6
- FWCI
- 2.17
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.